The domestic equity indices ended the last trading on a high. BSE Sensex ended 418 points higher, while Nifty gained 114 points. Today, both indices were corrected and opened a little lower. The overnight gains on Wall Street might lead to an upward movement on Dalal Street today. 

Ex-dividend: Shares of Tata Chemicals, Canara Bank, and Shankara Building Products will trade ex-dividend today. 

F&O Ban: Six stocks – Delta Corp, India Cements, Indiabulls Housing Finance, BHEL, Manappuram Finance and Indian Energy Exchange (IEX) – will be under F&O ban on Wednesday.

Adani Group: The Gautam Adani-led group seeks to refinance up to $3.8 billion of loan facility taken last year to acquire Ambuja Cements Ltd. It is in talks with lenders, including global banks, to decide whether to convert the original loan into debt with an extended maturity period. It expects to conclude the process within four months. 

Anupam Rasayan: The chemical maker said in a regulatory filing on Tuesday that it has signed a Rs 2,186 crore Letter of Intent (LoI) with a Japanese speciality chemical company for the supply of a new age patented life science active ingredient for the next five years, subject to successful validation within the next 18 months. 

Zee Entertainment Enterprises: Sony Corporation will likely seek a fresh forensic audit of the company after SEBI issued an interim order banning Zee’s promoters, Subhash Chandra and Punit Goenka, from taking key positions in listed companies. The promoters are seeking a stay on the interim order. Meanwhile, Plutus Wealth Management bought a 0.78% stake or 75 lakh equity shares in the media company at an average price of Rs 191.44 per share, amounting to Rs 143.58 crore.

Zydus Life Sciences: The United States Food and Drug Administration (USFDA) concluded a current good manufacturing practice inspection on Tuesday at Zydus Biotech Park in Changodar, Ahmedabad, with nil observations. The company has also received final approval from the regulator to market Varenicline Tablets and Diclofenac Sodium/ Misoprostol delayed-release tablets in the US.  

Nazara Technologies: Societe Generale, a Europe-based financial services group, sold 4 lakh shares or 0.6% stake in the gaming and sports media platform via bulk deals at an average price of Rs 681.74 per share.